Stay informed with evidence-based insights, educational webinars, and practical tools from PharmD Live®’s experts in chronic care, medication optimization, and value-based care.
Stay informed with evidence-based insights, educational webinars, and practical tools from PharmD Live®’s experts in chronic care, medication optimization, and value-based care.
Blog, Chronic Disease
Understanding Medicare’s Chronic Care Management (CCM) program is essential for providers seeking to enhance patient
Beers Criteria
The American Geriatrics Society (AGS) recently released its latest update to a highly utilized reference
Beers Criteria
By Hannah Grice, PharmD The Beers Criteria®1 is a leading source of expert information about potentially
Beers Criteria
Potentially Inappropriate Medication Use in Older Adults with Chronic Diseases The American Geriatrics Society (AGS) Beers Criteria®
Alzheimers
by Giftina Wilson, PharmD Candidate On June 7, 2021, the FDA approved the controversial Aduhelm® (aducanumab)
Alzheimers
By Minitha Jacob, PharmD Candidate, and Hannah Grice, PharmD Alzheimer’s disease (AD) is considered the most
Advanced Primary Care Management (APCM)
Meeting the Moment in Primary Care The shift to value-based care in the U.S. is
Uncategorized
LAS VEGAS, June 27, 2024 /PRNewswire/ — PharmD Live®, a virtual clinical pharmacist solutions leader, is proud to
Press Release
WASHINGTON, February 18, 2025 – PharmD Live®, an innovative pharmacist-led virtual care solution powered by
Blog, Chronic Disease
Understanding Medicare’s Chronic Care Management (CCM) program is essential for providers seeking to enhance patient
Beers Criteria
The American Geriatrics Society (AGS) recently released its latest update to a highly utilized reference
Beers Criteria
By Hannah Grice, PharmD The Beers Criteria®1 is a leading source of expert information about potentially
Beers Criteria
Potentially Inappropriate Medication Use in Older Adults with Chronic Diseases The American Geriatrics Society (AGS) Beers Criteria®
Alzheimers
by Giftina Wilson, PharmD Candidate On June 7, 2021, the FDA approved the controversial Aduhelm® (aducanumab)
Alzheimers
By Minitha Jacob, PharmD Candidate, and Hannah Grice, PharmD Alzheimer’s disease (AD) is considered the most
Advanced Primary Care Management (APCM)
Meeting the Moment in Primary Care The shift to value-based care in the U.S. is
Uncategorized
LAS VEGAS, June 27, 2024 /PRNewswire/ — PharmD Live®, a virtual clinical pharmacist solutions leader, is proud to
Press Release
WASHINGTON, February 18, 2025 – PharmD Live®, an innovative pharmacist-led virtual care solution powered by
